Catalyst Wire Dossier Catalyst Wire Dossier

BEIZRAY

Docetaxel · Zydus Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BEIZRAY, covering 2024-10-23 to 2025-04-22. Get the full timeline:

Most recent: FDA Approved: BEIZRAY — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

See pricing